Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The European Journal of Health Economics
Published in: The European Journal of Health Economics 2/2005

01-06-2005 | Original papers

Validating the EQ-5D with time trade off for the German population

Authors: W. Greiner, C. Claes, J. J. V. Busschbach, J.-M. Graf von der Schulenburg

Published in: The European Journal of Health Economics | Issue 2/2005

Login to get access

Abstract

The aim of this survey study was to derive the societal values of the general public for the EuroQol EQ-5D. Using the same protocol as previously used in the United Kingdom, we compared the German values with the British. In face-to-face interviews a sample of 339 individuals in northern Germany valued 15 different health states from a sample of 36 states. Values were derived using the York MVH protocol for time trade-off (TTO) and a visual analogue scale (VAS). Values for all 243 health states of the EQ-5D were estimated by a regression model. The VAS values revealed close a resemblance to the British VAS results. German TTO values were higher than the British. This was especially the case for the worse health states. The results suggest that the TTO values are more related to national variables than values derived by VAS. The use of the TTO values of this investigation makes it possible to anticipate these cultural differences in studies carried out in Germany.
Literature
1.
Badia X et al (1999) Inconsistent responses in three preference-elicitation methods for health states. Soc Sci Med 49:943–50
2.
Badia X et al (2001) A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making 21:7–16
3.
Brazier JE (2002) The estimation a preference-based single index measure for health from the SF-36. J Health Econ 21:271–292CrossRefPubMed
4.
5.
Busschbach JJV et al (1997) Testing different parametric relations between the EuroQol health description and health valuation in students. In: Nord E (ed) Conference Proceedings of the EuroQol Plenary Meeting Oslo, 17–19 Oct 1996. National Institute of Public Health: Oslo
6.
Busschbach JJV et al (2003) A comparison of EQ-5D time tarde-off values obtained in Germany, the United Kingdom and Spain. In: Brooks R, Rabin R, de Charro F (eds) The measurement and valuation of health status using EQ-5D—a European perspective. Kluwer: Dordrecht, pp143–165
7.
8.
Greiner W et al (2003) A European EQ-5D VAS valuation set. In: Brooks R, Rabin R, de Charro F (eds) The measurement and valuation of health status using EQ-5D—a European perspective. Kluwer: Dordrecht, pp 103–142
9.
Macran S, Kind P (2000) Valuing the EQ-5D health states using a modified MVH protocol: preliminary results. In: Badia X, Herdman M, Roset M (eds) Stiges plenary meeting of the EuroQol Group 6–9 November 1999, Spain. Institut de Salut Publica de Catalunya: Barcelona
10.
Patrick DL, Starks HE, Cain KC, Uhlmann AF, Pearlman R (1994) Measuring preferences for health status worse than death. Med Decis Making 14:9–18
11.
Torrance G (1986) Measurement of health state utilities for economic appraisal. J Health Econ 5:1–30
12.
Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, Hamashima C, Hisashige A, Tamura M (2002) Estimating an EQ-5D population value set: the case of Japan. Health Econ 11:341–353
Metadata
Title
Validating the EQ-5D with time trade off for the German population
Authors
W. Greiner
C. Claes
J. J. V. Busschbach
J.-M. Graf von der Schulenburg
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
The European Journal of Health Economics / Issue 2/2005
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-004-0264-z

Other articles of this Issue 2/2005

The European Journal of Health Economics 2/2005 Go to the issue

Pricing and reimbursement

German health care system in transition

Original Papers

Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon α-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany

❚

Costs of hospitalization for severe acute asthma of patients not treated according to guidelines and recommendations

Original Papers

Order bias in estimates of willingness to pay for drugs to treat attention-deficit/hyperactivity disorder

Original Papers

The direct medical cost of diabetes in Israel

Original papers

Cost of home palliative care compared with conventional hospital care for patients with haematological cancers in Greece